Renaissance Technologies’s BELLUS Health Inc. BLU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-290,375
Closed -$2.09M 4402
2023
Q1
$2.09M Buy
290,375
+89,637
+45% +$695K ﹤0.01% 2002
2022
Q4
$1.65M Buy
+200,738
New +$1.87M ﹤0.01% 2197
2022
Q3
Sell
-64,938
Closed -$598K 4531
2022
Q2
$598K Sell
64,938
-142,711
-69% -$1.17M ﹤0.01% 3051
2022
Q1
$1.44M Buy
207,649
+179,011
+625% +$1.15M ﹤0.01% 2473
2021
Q4
$230K Buy
+28,638
New +$190K ﹤0.01% 3459
2021
Q1
Sell
-56,400
Closed -$173K 3829
2020
Q4
$173K Buy
+56,400
New +$153K ﹤0.01% 3168
2020
Q3
Sell
-65,438
Closed -$677K 3789
2020
Q2
$677K Buy
65,438
+5,339
+9% +$54.1K ﹤0.01% 2749
2020
Q1
$597K Sell
60,099
-22,539
-27% -$201K ﹤0.01% 2670
2019
Q4
$627K Buy
82,638
+44,200
+115% +$302K ﹤0.01% 2816
2019
Q3
$247K Buy
+38,438
New +$271K ﹤0.01% 3089

Other funds holding BLU

Renaissance Technologies's BLU Position: Q2 2023 in Review

Renaissance Technologies sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 290,375 shares — an estimated $2.09M sold.

Renaissance Technologies first reported a position in BLU in Q3 2019 and held it in 10 quarters. The position peaked at $2.09M in Q1 2023. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • Renaissance Technologies reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • Renaissance Technologies sold 290,375 BELLUS Health Inc. shares in Q2 2023, an estimated $2.09M.
  • Renaissance Technologies first reported a position in BELLUS Health Inc. in Q3 2019 and held it in 10 quarters.
  • Renaissance Technologies's BELLUS Health Inc. position peaked at $2.09M in Q1 2023.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.